KOACT US CNS THERAPEUTICS ACTIVEKOACT US CNS THERAPEUTICS ACTIVEKOACT US CNS THERAPEUTICS ACTIVE

KOACT US CNS THERAPEUTICS ACTIVE

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪9.87 B‬KRW
Fund flows (1Y)
‪−124.69 M‬KRW
Dividend yield (indicated)
Discount/Premium to NAV
−1.2%

About KOACT US CNS THERAPEUTICS ACTIVE


Issuer
Samsung Life Insurance Co., Ltd.
Brand
Samsung
Expense ratio
0.50%
Inception date
Sep 3, 2024
Management style
Active
ISIN
KR7490330008
The fund is actively managed ETF that seeks to outperform the daily performance of Solactive US CNS Therapeutics index by mainly investing in U.S. listed companies related to CNS Therapeutics.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Health care equipment & services
Weighting scheme
Proprietary
Selection criteria
Proprietary

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of November 21, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Cash
Stocks48.51%
Health Technology48.51%
Bonds, Cash & Other51.49%
Cash51.49%
Stock breakdown by region
100%
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows